Shares the worst performer in the Nasdaq 100
Tesla Inc. shares slid Friday in the wake of Chief Executive Elon Musk appearing to mock the U.S. Securities and Exchange Commission and renewing his criticism of short sellers less than a week after reaching an agreement with regulators on fraud charges.
Critical information for the U.S. trading day
Get ready to hit the ground running.
S&P 500, Nasdaq book worst day since June
Opinion: Report of Chinese spy chip adds to company’s accounting troubles
Concentration is ‘a feature and not a bug’ of the stock market
Nikkei sags as yen gains; Apple suppliers fall in Hong Kong, Taiwan
Guardant Health shares popped almost 70 percent in their first day of trading on Thursday.
The Silicon Valley oncology company, backed by SoftBank, sold 12.5 million shares at $19 in its initial public offering. The stock was up more than 80 percent in mid-afternoon trading but later pared some of those gains, closing up 69.47 percent at $32.20 per share.
J.P. Morgan is getting less optimistic about the trade conflict between the U.S. and China.
The firm lowered its rating for Chinese equities to neutral from overweight, predicting the escalating trade war between the countries will affect China’s economy next year.
Facebook will come back stronger than ever from its data privacy scandals, so invest now, RBC Capital Markets’ lead internet analyst told CNBC on Thursday.
Intel has been lagging the semis as a whole this year, but TradingAnalysis.com founder Todd Gordon says the charts are pointing to a breakout for the chipmaker.
Neurogene reports death of Rett patient left in critical condition by high dose of gene therapy
Philips raises curtain on next-gen helium-sealed MRI scanner
Pyxis’ shares tumble after early ADC readout in solid tumors fails to spark inspiration: analyst
Flagship-backed Sonata says sayonara to CEO, trims crew by 20 staffers
Weekly Market Review – February 8, 2025
Versant unveils Pep2Tango, a next-gen peptide biotech hoping to redefine obesity treatment
BD teams up with MD Anderson, Su Clinica to study HPV self-collection tests in underserved Texas communities
After ProfoundBio buy, Genmab open to more M&A if it makes ‘strategic sense,’ CFO says
Enveda raises $130M series C to take more AI-discovered compounds into the clinic
Intuitive Surgical stock surges 10% amid da Vinci 5 demand, with full rollout set for 2025
